Evidence map›Paper›PMID 42741602›Full record

ArticleERJ open research2026

Achieving clinical remission in moderate-to-severe asthma using inhaled triple therapy.

Giorgio Walter Canonica, Dave Singh, Alberto Papi, Guy Brusselle, Alessio Piraino, Laura Franzini, Andrea Vele, Gemzel Hernandez, Gwen Skloot, J Christian Virchow

Abstract read
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giorgio Walter CanonicaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.ORCID https://orcid.org/0000-0001-8467-2557
Dave SinghMedicines Evaluation Unit, Manchester, UK.
Alberto PapiRespiratory Unit, Sant'Anna University Hospital, Ferrara, Italy.ORCID https://orcid.org/0000-0002-6924-4500
Guy BrusselleDepartment of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0001-7021-8505
Alessio PirainoGlobal Medical Affairs, Chiesi Farmaceutici, Parma, Italy.
Laura FranziniGlobal Medical Affairs, Chiesi Farmaceutici, Parma, Italy.
Andrea VeleGlobal Clinical Development, Chiesi Farmaceutici, Parma, Italy.
Gemzel HernandezGlobal Clinical Development, Chiesi Farmaceutici, Parma, Italy.
Gwen SklootGlobal Clinical Development, Chiesi Farmaceutici, Parma, Italy.
J Christian VirchowDepartment of Pneumology/Intensive Care Medicine, University of Rostock, Rostock, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is growing interest in evaluating the ability of treatments to deliver clinical remission in patients with asthma. We conducted Methods: Clinical remission was defined as: no use of oral corticosteroids over 52 weeks, no occurrence of severe exacerbations over 52 weeks, Asthma Control Questionnaire-5 score <1.5 at weeks 26, 40 and 52, and pre-dose forced expiratory volume in 1 s at week 52 equal to, or higher than, the baseline value. Results: Of 2291 patients included in these analyses, 598 (26.1%) met the clinical remission definition ( Conclusions: Among patients with asthma that was uncontrolled by an inhaled corticosteroid (ICS)/long-acting β

Identifiers

PMID42741602
PMCPMC13573224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.